"Designing Growth Strategies is in our DNA"

Antiviral Drugs Market Size, Share & Industry Analysis, By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2019-2026

The global antiviral drugs market size stood at USD 36.1 billion in 2018 and is projected to reach USD 44.2 billion by 2026, exhibiting a CAGR of 3.2% during the forecast... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Feb, 2020 | Report ID: FBI102190 | Status : Published

 

Request a Free Sample Copy

Refresh Button
Antiviral Drugs Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 130
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X